Treatment, diagnostic, and method for discovering antagonist using SPARC specific miRNAs

Details for Australian Patent Application No. 2009222056 (hide)

Owner Abraxis BioScience, LLC

Inventors Hwang, Larn; Trieu, Vuong; Desai, Neil

Agent Pizzeys

Pub. Number AU-A-2009222056

PCT Pub. Number WO2009/111375

Priority 61/032,961 01.03.08 US

Filing date 2 March 2009

Wipo publication date 11 September 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/111375 Priority application(s): WO2009/111375

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009222060-Control and optimization system

2009222053-Methods and devices for monitoring of frying oil quality